elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34347172-A1761EE1-A38C-4B54-A2D7-85CF2EC0A8A6
Q34347172-A1761EE1-A38C-4B54-A2D7-85CF2EC0A8A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34347172-A1761EE1-A38C-4B54-A2D7-85CF2EC0A8A6
Novel approaches to treatment of double-refractory multiple myeloma.
P2860
Q34347172-A1761EE1-A38C-4B54-A2D7-85CF2EC0A8A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34347172-A1761EE1-A38C-4B54-A2D7-85CF2EC0A8A6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3c946db6ddd5868d7a88f1977523618bf0553de6
P2860
Design and rationale of FOCUS (PX-171-011): a randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)